Annual EBITDA
-$11.71 M
+$14.46 M+55.25%
31 December 2022
Summary:
Scopus BioPharma annual earnings before interest, taxes, depreciation & amortization is currently -$11.71 million, with the most recent change of +$14.46 million (+55.25%) on 31 December 2022. During the last 3 years, it has fallen by -$1.56 million (-15.35%). SCPS annual EBITDA is now -1607.45% below its all-time high of -$686.00 thousand, reached on 31 December 2018.SCPS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.93 M
-$249.10 K-9.30%
30 June 2023
Summary:
Scopus BioPharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.93 million, with the most recent change of -$249.10 thousand (-9.30%) on 30 June 2023. SCPS quarterly EBITDA is now -2290.61% below its all-time high of -$122.50 thousand, reached on 01 March 2018.SCPS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$9.34 M
+$390.50 K+4.01%
30 June 2023
Summary:
Scopus BioPharma TTM earnings before interest, taxes, depreciation & amortization is currently -$9.34 million, with the most recent change of +$390.50 thousand (+4.01%) on 30 June 2023. SCPS TTM EBITDA is now -7526.04% below its all-time high of -$122.50 thousand, reached on 01 March 2018.SCPS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -15.3% | -127.1% | +54.1% |
| 5 y5 years | -1607.5% | -267.4% | -441.2% |
SCPS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -15.3% | +55.3% | -127.1% | +55.1% | at high | +66.3% |
| 5 y | 5 years | -1607.5% | +55.3% | -373.2% | +80.9% | -441.2% | +66.3% |
| alltime | all time | -1607.5% | +55.3% | -2290.6% | +80.9% | -7526.0% | +66.3% |
Scopus BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$2.93 M(+9.3%) | -$9.34 M(-4.0%) |
| Mar 2023 | - | -$2.68 M(+46.0%) | -$9.73 M(-16.9%) |
| Dec 2022 | -$11.71 M(-55.3%) | -$1.84 M(-3.3%) | -$11.71 M(-28.6%) |
| Sept 2022 | - | -$1.90 M(-42.8%) | -$16.40 M(+3.9%) |
| June 2022 | - | -$3.32 M(-28.8%) | -$15.79 M(-43.1%) |
| Mar 2022 | - | -$4.66 M(-28.5%) | -$27.76 M(+6.1%) |
| Dec 2021 | -$26.18 M(+157.8%) | -$6.52 M(+405.6%) | -$26.18 M(+28.5%) |
| Sept 2021 | - | -$1.29 M(-91.6%) | -$20.37 M(+2.1%) |
| June 2021 | - | -$15.30 M(+397.8%) | -$19.96 M(+58.3%) |
| Mar 2021 | - | -$3.07 M(+330.5%) | -$12.61 M(+24.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$10.15 M(+277.6%) | -$713.80 K(-18.4%) | -$10.15 M(-2.4%) |
| Sept 2020 | - | -$875.10 K(-89.0%) | -$10.40 M(+0.8%) |
| June 2020 | - | -$7.95 M(+1183.7%) | -$10.32 M(+266.6%) |
| Mar 2020 | - | -$618.90 K(-35.8%) | -$2.82 M(+4.7%) |
| Dec 2019 | -$2.69 M(+292.0%) | -$963.30 K(+20.8%) | -$2.69 M(+55.8%) |
| Sept 2019 | - | -$797.20 K(+82.3%) | -$1.73 M(+85.8%) |
| June 2019 | - | -$437.20 K(-11.1%) | -$928.90 K(+44.3%) |
| Mar 2019 | - | -$491.70 K(+223.1%) | -$643.90 K(+134.4%) |
| Dec 2018 | -$686.00 K | - | - |
| June 2018 | - | -$152.20 K(+24.2%) | -$274.70 K(+124.2%) |
| Mar 2018 | - | -$122.50 K | -$122.50 K |
FAQ
- What is Scopus BioPharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Scopus BioPharma?
- What is Scopus BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Scopus BioPharma?
- What is Scopus BioPharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Scopus BioPharma?
What is Scopus BioPharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SCPS is -$11.71 M
What is the all time high annual EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$686.00 K
What is Scopus BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SCPS is -$2.93 M
What is the all time high quarterly EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$122.50 K
What is Scopus BioPharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SCPS is -$9.34 M
What is the all time high TTM EBITDA for Scopus BioPharma?
Scopus BioPharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$122.50 K